JQM-28621-60228
3 vaccinations
2 coded responses
18 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 787 / TX
- Registered
- 2022-06-28
- Relationship
- Child or adolescent in my care
- Guardian
- 88D-23277-89649
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-23
Dose 1 — Pfizer-BioNTech
-
2022-06-28
Registered in v-safe
-
2022-06-29
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Irritability/crying, Loss of appetite · Be unable to do your normal daily activitiesUnder 3 check-in
- 2022-06-30
- 2022-07-07
- 2022-07-14
-
2022-07-16
Dose 2 — Pfizer-BioNTech
-
2022-09-28
Dose 3 — Pfizer-BioNTech
- 2022-09-28
-
2022-09-29
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-10-01
-
2022-10-02
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Fair · Irritability/crying · Be unable to do your normal daily activitiesUnder 3 check-in
- 2022-10-03
-
2022-10-04
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Fair · Irritability/cryingUnder 3 check-in
-
2022-10-05
Health check-in — day 7, dose 3, under 3Feeling: Good · None · Be unable to do your normal daily activitiesUnder 3 check-in
- 2022-10-12
- 2022-10-19
- 2022-10-26
- 2022-11-02
-
2022-11-09
Survey response — day 42, dose 3, under 3MedDRA: Nasal congestion, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Got some running nose and nasal congestion.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-28
Survey response — 3 months, dose 3, under 3MedDRA: Nasal congestion, Rhinorrhoea — Feeling: Good · Be unable to do your normal daily activitiesFree text: Nasal congestion, runny nose.MedDRA releases: 2024-11 · check-in free text available
- 2023-03-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-23 | Pfizer-BioNTech | No |
| 2 | 2022-07-16 | Pfizer-BioNTech | No |
| 3 | 2022-09-28 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — day 42, dose 3, under 3
Symptoms: Got some running nose and nasal congestion.
Release 12 (Under 3) — 3 months, dose 3, under 3
Symptoms: Nasal congestion, runny nose.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasal congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release